MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5.

MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5. Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8242 Authors: Wang DZ, Jing SF, Hao SB, Huang XY, Miao QT, Gao JF Abstract Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "MiR-218 promotes apoptosis of U2OS osteosarcoma cells through targeting BIRC5, by D.-Z. Wang, S.-F. Jing, S.-B. Hao, X.-Y. Huang, Q.-T. Miao, J.-F. Gao, published in Eur Rev Med Pharmacol Sci 2018; 22(20): 6650-6657-DOI: 10.26355/eurrev_201810_16140-PMID: 30402837" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/16140. PMID: 32894525 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research